Clinical Trial Update: Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study [NA]

View source ↗

Summary

Completed proof-of-concept clinical trial evaluating the ability of MRI spectroscopy to delineate tumor areas enriched for glioblastoma stem cells.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Glioblastoma | NA | Status: COMPLETED